Highlights
(1) Pinpoints three key bottlenecks (insufficient targeting, low bioavailability, poor stability) that impede the clinical application of food-medicine homologous active polysaccharides.
(2) Proposes a novel "carrier adaptation-targeted modification-environmental response" synergistic strategy to tackle the precision delivery challenges of these polysaccharides.
(3) Offers a comprehensive solution to enhance the targeting, bioavailability and stability of the polysaccharides, advancing functional foods toward precision nutrition and supporting chronic disease prevention.

京公网安备11010802044758号
Comments on this article